Stock RIV CANOPY RIVERS J SV A
Add to a list
To use this feature you must be a member
Log inSign up

Financials CANOPY RIVERS J SV A Toronto S.E.

Equities

RIV

CA7680141024

Pharmaceuticals

End-of-day quote Toronto S.E.
Other stock markets
 23:00:00 21/09/2021 BST 		5-day change 1st Jan Change
1.52 CAD +1.67% Intraday chart for CANOPY RIVERS J SV A -7.41% +28.21%
04-30 RIV Capital Inc. Reports Earnings Results for the Nine Months Ended December 31, 2023 CI
02-14 RIV Capital Reports Opening of Adult-Use Dispensary in White Plains, New York, by Etain MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 375.3 165.7 176.7 163.4 25.38 10.76
Enterprise Value (EV) 2 329.5 61.75 130.7 35.89 -272.2 52.89
P/E ratio 5.72 x 43.9 x -4.18 x -1.59 x -0.42 x -0.13 x
Yield - - - - - -
Capitalization / Revenue 6.85 x 4.31 x 14.5 x 12.2 x 13.4 x 1.45 x
EV / Revenue 6.02 x 1.6 x 10.7 x 2.67 x -144 x 7.15 x
EV / EBITDA - - -17,751,448 x -583,098 x 20,912,941 x -3,162,548 x
EV / FCF - 2,409,207 x -24,692,125 x -4,195,596 x 6,764,769 x -2,072,086 x
FCF Yield - 0% -0% -0% 0% -0%
Price to Book 1.53 x 0.4 x 0.58 x 0.52 x 0.07 x 0.26 x
Nbr of stocks (in thousands) 166,954 188,983 192,369 142,445 163,855 135,813
Reference price 3 2.248 0.8770 0.9186 1.147 0.1549 0.0792
Announcement Date 21/08/18 16/07/19 03/06/20 03/06/21 13/06/22 30/04/24
1USD in Million2CAD in Million3USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 54.78 38.48 12.19 13.43 1.896 7.397
EBITDA - - -7.362 -61.56 -13.01 -16.72
EBIT 1 46.81 8.027 -7.381 -61.59 -13.08 -20.42
Operating Margin 85.45% 20.86% -60.54% -458.6% -690.08% -276.01%
Earnings before Tax (EBT) 1 46.74 8.343 -40.62 -152.4 -65.2 -105.7
Net income 1 39.67 3.918 -40.57 -133.9 -52.73 -85.13
Net margin 72.42% 10.18% -332.75% -996.87% -2,781.17% -1,150.76%
EPS 2 0.3927 0.0200 -0.2200 -0.7200 -0.3702 -0.6267
Free Cash Flow - 25.63 -5.293 -8.555 -40.23 -25.53
FCF margin - 66.61% -43.41% -63.7% -2,121.95% -345.08%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - 654.16% - - - -
Dividend per Share - - - - - -
Announcement Date 21/08/18 16/07/19 03/06/20 03/06/21 13/06/22 30/04/24
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - 42.1
Net Cash position 1 45.8 104 46 127 298 -
Leverage (Debt/EBITDA) - - - - - -2.519 x
Free Cash Flow - 25.6 -5.29 -8.56 -40.2 -25.5
ROE (net income / shareholders' equity) - 1.31% -11.5% -43.9% -16.4% -96%
ROA (Net income/ Total Assets) - 1.6% -1.28% -12.1% -2.06% -3.36%
Assets 1 - 245.4 3,164 1,106 2,557 2,530
Book Value Per Share 2 1.470 2.180 1.580 2.190 2.320 0.3100
Cash Flow per Share 2 0.3500 0.5600 0.2500 0.9000 2.790 0.6000
Capex - - - - - 3.79
Capex / Sales - - - - - 51.21%
Announcement Date 21/08/18 16/07/19 03/06/20 03/06/21 13/06/22 30/04/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Alternative Medicine

1st Jan change Capi.
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+40.09% 6.16B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-16.34% 4.46B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-7.11% 3.27B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+5.14% 3.2B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-0.18% 2.6B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+47.93% 1.98B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-7.15% 1.7B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+0.67% 1.66B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-8.73% 1.61B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. RIV Stock
  4. RIV Stock
  5. Financials CANOPY RIVERS J SV A